On 25 March 2021, the company Glycom A/S (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place 3-Fucosyllactose (‘3-FL’) obtained by microbial fermentation using a genetically modified strain of E. coli K-12 DH1, on the Union market as a novel food. The applicant requested for 3-FL to be used in infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 of the European Parliament and of the Council [Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (OJ L 181, 29.6.2013, p. 35).], unflavoured pasteurised and unflavoured sterilised (including UHT) milk products, unflavoured and flavoured fermented milk-based products including heat-treated products, cereal bars, milk based drinks and similar products, foods for special medical purposes as defined in Regulation (EU) No 609/2013, beverages (flavoured drinks, excluding drinks with a pH less than 5), total diet replacement for weight control as defined in Regulation (EU) No 609/2013, and in food supplements as defined in Directive 2002/46/EC of the European Parliament and of the Council [Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51).] intended for the general population. Subsequently, on 15 June 2023, the applicant modified the initial request in the application on the use of 3-FL in food supplements to exclude infants and young children. Concerning the conditions of use, the applicant also proposed that food supplements containing 3-FL should not be used if other foods with added 3-FL are consumed the same day.
Recital 5, Regulation (EU) 2023/2210
In forcesince 20 Oct 2023
Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 201…Law
- celex=31946L2002
- celex=31992L0052
- celex=31999L0021
- celex=32006L0141
- celex=32009L0039
- celex=32009R0041
- celex=32009R0953
- num:eu=1941/2009
- num:eu=1992/52
- num:eu=1999/21